When your products affect the health of millions, you can’t afford to make mistakes. As one of the largest pharmaceutical corporations in the world, Pfizer is committed to producing medications that consumers can depend on. Popular go-to’s like Advil, Centrum, Lyrica, Zoloft, Celebrex, and EpiPen are just a few of Pfizer’s successes. Pfizer’s Global Research and Development scientists use trusted resources to streamline production and yield accurate results. That’s why they’ve chosen MakerBot to help them develop an efficient way to test a new line of osteo and rheumatoid arthritis drugs. Scientists David Zakur and Edwin Berryman research and test new treatments in Pfizer’s Comparative Medicine Department. They’re in the midst of conducting research to treat arthritis, a disease that affects the bone and cartilage of joints. They’re able to examine how arthritic rat bones react to different experimental treatments through high resolution scans of the cartilage. This sounds simple enough, but the sample bone needs to be in the exact same position for each and every scan. Working with a limited budget, the scientists didn’t have thousands of dollars to spend on a holder that would keep the bones in place. They called on fellow Pfizer scientist Tim Winton to design and 3D print a bone holder. Using his MakerBot Replicator 3D Printer (5th Gen), Winton was able to create a holder that was stable enough to keep the bones steady. “Once the final design was complete we needed to print numerous holders. The Replicator’s consistency was showcased again by delivering exact duplications of the holders from print to print,” Winton shares. The new holders streamlined the entire process. With this increase in efficiency, Zakur and Berryman were able to speed through scanning, avoid outsourcing costs, and boost the accuracy of their research. Learn more about how Pfizer uses MakerBot to empower scientists and increase productivity in this case study.